Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 23, 2025
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure
GlobeNewswire
·
April 23, 2025
Initial Clinical Studies Completed with Significant Positive Results The Cleveland Clinic Foundation, Abbott Laboratories and a New Era Associates (NEA) fund to Acquire Economic Interests in VTAK Fort Mill, S.C., April 23, 2025 (GLOBE NEWSWIRE) -- Catheter …
Kestra Medical Technologies to Showcase Innovation in Sudden Cardiac Arrest Protection and Recovery at Heart Rhythm 2025
GlobeNewswire
·
April 23, 2025
KIRKLAND, Wash., April 23, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) (“Kestra”), a wearable medical device and digital healthcare company, announced today it will exhibit at Heart Rhythm 2025, the annual meeting of the Heart …
Beghou Consulting Prepares for Next Phase of Growth, Names Adrienne Lovink, Chief Services Officer, to Succeed Beth Beghou, Founder and CEO
GlobeNewswire
·
April 23, 2025
EVANSTON, Ill., April 23, 2025 (GLOBE NEWSWIRE) -- Beghou Consulting, a leading provider of data, analytics, and technology solutions for life sciences commercialization, today announced that Adrienne Lovink, Chief Services Officer, will assume the role of …
Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease
GlobeNewswire
·
April 23, 2025
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication in Genome Research demonstrating that optical genome Mapping (OGM) can be an accurate, cost-effective method for detecting and …
Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory Board
GlobeNewswire
·
April 23, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, …
Atea Pharmaceuticals to Present New Data Showcasing Potential Best-in-Class Regimen of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2025
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today …
BPGbio Presents New Research on Tumor Metabolism, Immunotherapy, and Diagnostics at AACR Annual Meeting 2025
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced the presentation of seven presentations at the American …
Breckenridge Distillery Announces Re-Release of Award-Winning Cognac Cask Finish Whiskey
GlobeNewswire
·
April 23, 2025
BRECKENRIDGE, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) spirits brand, today announced its newest addition to the brand …
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
GlobeNewswire
·
April 23, 2025
LOUISVILLE, Colo. and HERCULES, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and diagnostics products, …
Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025
GlobeNewswire
·
April 23, 2025
BROOMFIELD, Colo., April 23, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help …
The Ensign Group Schedules First Quarter Earnings Call for Wednesday, April 30, 2025
GlobeNewswire
·
April 23, 2025
SAN JUAN CAPISTRANO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …
Point of Care Hematology Diagnostics Market to Reach $3.0 Bn by 2027 in the short run and $3.6 Bn by 2030 Globally, at 5.8% CAGR: Allied Market Research
GlobeNewswire
·
April 23, 2025
Wilmington, Delaware, April 23, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Point of Care Hematology Diagnostics Market - Global Opportunity Analysis and Industry Forecast, 2024-2030", valued at $2.4 billion in 2023, is …
Codex Labs Bia Ultra-Hydrating Soothing Lotion Is Awarded Seal of Acceptance from National Eczema Association and Microbiome-Friendly Certification from MyMicrobiome
GlobeNewswire
·
April 23, 2025
San Jose, CA, USA, April 23, 2025 (GLOBE NEWSWIRE) -- Codex Labs, a Silicon Valley skintech company, announced that its Bia Ultra-Hydrating Soothing Lotion, the European version of its US Bia over-the-counter (OTC) Bia Eczema Relief Lotion has been awarded …
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
GlobeNewswire
·
April 23, 2025
Five abstracts accepted for poster presentations WARMINSTER, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, today …
ProDentim Complaints & Side Effects (EXPOSED) Investigative Consumer Report Examines Scientific Claims About ProDentim!
GlobeNewswire
·
April 23, 2025
AUSTIN, Texas, April 22, 2025 (GLOBE NEWSWIRE) -- ProDentim is a dental probiotic formula that fosters healthy teeth and gums by building a balanced ecosystem within the mouth. It addresses the root cause of oral conditions and eliminates pathogenic …
CMVC adquiere Orlando Medical Institute y expande su portafolio educativo en el campo de salud con programas de paramédico y atención médica de emergencia
GlobeNewswire
·
April 23, 2025
ORLANDO, Florida, April 22, 2025 (GLOBE NEWSWIRE) -- Compu-Med Vocational Careers (CMVC), anuncia la adquisición de Orlando Medical Institute (OMI). Esta adquisición estratégica acelera la expansión de los programas educativos en salud de CMVC al agregar …
浩鼎将在AACR发表七篇海报论文
GlobeNewswire
·
April 23, 2025
台北讯, April 23, 2025 (GLOBE NEWSWIRE) -- 浩鼎生技（TPEx: 4174.TWO）今日首次公布其自主开发的次世代GlycOBI®技术平台所开发抗体药物偶联体（ADC）OBI-902的非临床数据，显示其具备优异的药物动力学特性，并在多种具挑战性的实体肿瘤动物模型中展现持续的抗肿瘤活性，且优于目前已上市的TROP2 ADC，显示OBI-902具备成为同类最佳ADC的潜力。OBI-992则为采用半胱氨酸连接技术的TROP2靶向ADC，其耐药性特征异于现有同类产品。 在本次 …
浩鼎將在AACR發表七篇海報論文
GlobeNewswire
·
April 23, 2025
台北電, April 23, 2025 (GLOBE NEWSWIRE) -- 台灣浩鼎生技（TPEx: 4174. TWO）今首度公布其自主開發的次世代 GlycOBI® 技術平台所開發抗體藥物複合體（ADC）OBI-902 非臨床數據，具有優異的藥物動力學特性，以及在多種具挑戰性的實體腫瘤動物模型中展現持續的抗腫瘤活性，亦證明優於目前已上市的 TROP2 ADC，證明OBI-902 具有成為同類最佳ADC的潛力。OBI-992 為半胱胺酸連接技術的 TROP2 靶向 ADC，其耐藥性特徵有異於目前同類的 …
OBI Pharma Announces Poster Presentations at the AACR 2025 Annual Meeting for OBI-992 and OBI-902 Antibody-Drug Conjugates (ADCs), GlycOBI® and ThiOBI® ADC enabling technologies, the OBI-3424 prodrug, and Globo H (GH) science
GlobeNewswire
·
April 23, 2025
TAIPEI, Taiwan, April 23, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO) today announced nonclinical data for OBI-902, a potential best-in-class anti-TROP2 ADC developed using the next generation proprietary GlycOBI® technologies. OBI-902 …
Recursion to Present Preliminary Clinical Data from the Ongoing Phase 1b/2 trial of REC-4881 in FAP at Digestive Disease Week 2025
GlobeNewswire
·
April 23, 2025
Salt Lake City, UT, April 22, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, will present preliminary data during the 2025 Digestive Disease Week (DDW) meeting from …